Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul 22;60(8):4433-41.
doi: 10.1128/AAC.00594-16. Print 2016 Aug.

rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines

Affiliations
Review

rRNA Binding Sites and the Molecular Mechanism of Action of the Tetracyclines

Chinwe U Chukwudi. Antimicrob Agents Chemother. .

Abstract

The tetracycline antibiotics are known to be effective in the treatment of both infectious and noninfectious disease conditions. The 16S rRNA binding mechanism currently held for the antibacterial action of the tetracyclines does not explain their activity against viruses, protozoa that lack mitochondria, and noninfectious conditions. Also, the mechanism by which the tetracyclines selectively inhibit microbial protein synthesis against host eukaryotic protein synthesis despite conservation of ribosome structure and functions is still questionable. Many studies have investigated the binding of the tetracyclines to the 16S rRNA using the small ribosomal subunit of different bacterial species, but there seems to be no agreement between various reports on the exact binding site on the 16S rRNA. The wide range of activity of the tetracyclines against a broad spectrum of bacterial pathogens, viruses, protozoa, and helminths, as well as noninfectious conditions, indicates a more generalized effect on RNA. In the light of recent evidence that the tetracyclines bind to various synthetic double-stranded RNAs (dsRNAs) of random base sequences, suggesting that the double-stranded structures may play a more important role in the binding of the tetracyclines to RNA than the specific base pairs, as earlier speculated, it is imperative to consider possible alternative binding modes or sites that could help explain the mechanisms of action of the tetracyclines against various pathogens and disease conditions.

PubMed Disclaimer

Figures

FIG 1
FIG 1
(A) Structures of the 50S and 30S bacterial ribosomal subunits, showing the secondary structures of rRNA (orange) in association with ribosomal proteins (gray). (B) Structures of dsDNA and dsRNA, showing hydrogen bonds between bases (blue) and other intramolecular bonds (green). Structure templates were obtained from the Protein Data Bank (PDB) and drawn using Jmol (an open-source Java viewer for chemical structures in three dimensions).
FIG 2
FIG 2
Chemical structures of tetracycline antibiotics in three dimensions. Gray balls represent carbons in the rings, red balls represent oxygens, and blue balls represent nitrogens. Structure templates were obtained from the Protein Data Bank (PDB) and drawn using Jmol.
FIG 3
FIG 3
Graphic representation of the binding of tetracyclines to double-stranded segments of cellular RNA.
None

References

    1. Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. 2006. Minocycline for short-term neuroprotection. Pharmacotherapy 26:515–521. doi: 10.1592/phco. - DOI - PMC - PubMed
    1. Michaelis M, Kleinschmidt MC, Doerr HW, Cinatl J. 2007. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother 60:981–986. doi: 10.1093/jac/dkm307. - DOI - PubMed
    1. Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S. 2005. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:2003–2011. doi: 10.1001/jama.293.16.2003. - DOI - PubMed
    1. Debrah AY, Mand S, Specht S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Larbi J, Lawson B, Taylor M, Adjei O, Hoerauf A. 2006. Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis. PLoS Pathog 2:e92. doi: 10.1371/journal.ppat.0020092. - DOI - PMC - PubMed
    1. Ralph SA, D'Ombrain MC, McFadden GI. 2001. The apicoplast as an antimalarial drug target. Drug Resist Updat 4:145–151. doi: 10.1054/drup.2001.0205. - DOI - PubMed

MeSH terms

LinkOut - more resources